Arriola, E. http://orcid.org/0000-0001-8960-7519
Paredes-Lario, A.
García-Gomez, R.
Diz-Tain, P.
Constenla, M.
García-Girón, C.
Márquez, G.
Reck, M.
López-Vivanco, G.
Article History
Received: 20 September 2017
Accepted: 2 March 2018
First Online: 5 April 2018
Compliance with ethical standards
:
: Dr. Arriola has received personal fees from Boehringer Ingelheim, BMS, and Eli Lilly; travel expenses from Astra Zeneca and Boehringer Ingelheim. Dr. Diz-Tain has received research grants to institution from Astra-Zeneca, research grants from Astra-Zeneca, advisory honorarium from Boehringer Ingelheim, BMS and Eli Lilly, and travel grants from Bristol Myers Squibb, Pfizer, Roche and Merck and Co. Dr. Marquez is full-time employee of AstraZeneca. Dr. Reck has received honoraria for lectures and consultancy from AstraZeneca, Roche/Genentech, BMS, MSD, Merck, Lilly, Boehringer-Ingelheim, Pfizer, Novartis, Celgene. Dr. Paredes-Lario, Dr. García-Gómez, Dr. Constenla, Dr. García-Girón and Dr. López-Vivanco declare that they have no conflict of interest.
: This study has been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: All individual participants gave their informed consent prior to their inclusion in the study.